Loading…
3 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Davit Tatishvilis Samed… | Healthcare Services | 13.6% | 60th pct | 268 |
| Gumbati Group | Construction | 14.7% | 56th pct | 582 |
| Gumbati Holding+ | (unclassified) | -133596.1% | 1st pct | 1208 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Gumbati Group | Davit Tatishvilis Samed… | Gumbati Holding+ |
|---|---|---|---|
| Margins | |||
| Gross Margin | 21.5% | 100.0% | 100.0% |
| EBITDA Margin | 14.7% | 13.6% | -133596.1% |
| EBITDAR | 6,209 | 810 | -2,573 |
| EBITDAR Margin | 15.1% | 24.5% | -133596.1% |
| EBIT Margin | 14.5% | 11.0% | -138901.1% |
| Net Profit Margin | 16.7% | 12.1% | -146146.8% |
| Operating Expense % of Sales | 6.7% | 86.4% | 133696.1% |
| Returns | |||
| Return on Assets (ROA) | 16.2% | 39.0% | -4.4% |
| Return on Equity (ROE) | 45.7% | 156.3% | -20.0% |
| ROIC [EBIT / Invested Capital] | 24.1% | 107.1% | -13.8% |
| Leverage & debt balances | |||
| Debt-to-Assets | 23.0% | 8.7% | 8.7% |
| Debt-to-Equity | 0.65x | 0.35x | 0.40x |
| Debt-to-EBITDA | 1.61x | 0.20x | N/A |
| Equity-to-Assets | 35.5% | 25.0% | 21.9% |
| Net Debt | 9,698 | 84 | 5,324 |
| Cash & Equivalents | 92 | 5 | 290 |
| Total Debt | 9,790 | 90 | 5,614 |
| Liquidity & working capital | |||
| Current Ratio | 1.40x | 0.36x | 1.43x |
| Quick Ratio | 0.84x | 0.36x | 1.43x |
| Cash Ratio | 0.00x | 0.01x | 0.01x |
| Total Current Assets | 25,886 | 164 | 64,124 |
| Total Current Liabilities | 18,493 | 453 | 44,791 |
| Inventory | 10,266 | N/A | N/A |
| Trade Receivables | 5,935 | 135 | 11 |
| Trade Payables | 2,419 | 453 | 3,747 |
| Net Working Capital | 7,393 | -289 | 19,333 |
| Net Working Capital % of Revenue | 17.9% | -8.8% | 1003772.0% |
| Trade Working Capital | 13,782 | -318 | -3,736 |
| Trade Working Capital % of Revenue | 33.4% | -9.6% | -193986.3% |
| Change in Trade Working Capital | N/A | N/A | N/A |
| Turnover & efficiency | |||
| Inventory Turnover | 3.16x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 115.7 | N/A | N/A |
| Receivables Turnover | 6.95x | 24.41x | 0.17x |
| Days Sales Outstanding (DSO) | 52.5 | 15.0 | 2118.7 |
| Payables Turnover | 13.39x | N/A | N/A |
| Days Payable Outstanding (DPO) | 27.3 | N/A | N/A |
| Cash Conversion Cycle | 140.9 days | 15.0 days | 2118.7 days |
| Asset Turnover | 0.97x | 3.22x | 0.00x |
| Cash flow & dividends | |||
| Operating Cash Flow | 5,083 | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | -2,772 | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | 83.7% | N/A | N/A |
| Dividends Declared | 1,106 | N/A | N/A |
| Dividend Payout Ratio | 16.0% | N/A | N/A |